TGF-β produced by inflammatory cells, including neutrophils and macrophages, plays a substantial role in tumor initiation and progression [51], and studies have shown that blockage of TGF-β significantly increased the effects of anticancer treatments [52,53]. Here, TGFB1 is linked to neoplasm.